Abstract
In an attempt to raise anti-Tn antibodies, an α-N-acetyl-D-galactosamine glycosylated peptide based on the tandem repeat of the intestinal mucin MUC2 was used as an immunogen. The MUC2 peptide (PTTTPISTTTMVTPTPTPTC) was glycosylated in vitro using concentrated α-N-acetylgalactosaminyltransferases activity from porcine submaxillary glands which resulted in the incorporation of 8–9 mol of Ga/NAc. Rabbits and mice developed specific anti-MUC2-GalNAc glycopeptide antibodies and no detectable anti-Tn antibodies. Anti-glycopeptide antibodies did not show reactivity with the unglycosylated MUC2 peptide or with other GalNAc glycosylated peptides. A mouse monoclonal antibody (PMH1) representative of the observed immune response was generated and its immunohistological reactivity analysed in normal tissues. PMH1 reacted similarly to other anti-MUC2 peptide antibodies. However, in some cells the staining was not restricted to the supranuclear area but extended to the entire cytoplasm. In addition, PMH1 reacted with purified colonic mucin by Western blot analysis suggesting that PMH1 reacted with some glycoforms of MUC2. The present work presents a useful approach for development of anti-mucin antibodies directed to different glycoforms of individual mucins.
Similar content being viewed by others
References
Springer GF (1984) Science 224: 1198–206.
Henningsson CM, Selvaraj S, MacLean GD, Suresh MR, Noujaim AA, Longenecker BM (1987) Cancer Immunol Immunother 25: 231–41.
Singhal A, Fohn M, Hakomori S (1991) Cancer Res 51: 1406–11.
O'Boyle KP, Zamore R, Adluri S, Cohen A, Kemeny N, Welt S, Lloyd KO, Oettgen HF, Old LJ, Livingston PO (1992) Cancer Res 52: 5663–7.
MacLean GD, Reddish M, Koganty RR, Wong T, Gandhi S, Smolenski M, Samuel J, Nabholtz JM, Longenecker BM (1993) Cancer Immunol Immunother 36: 215–22.
O'Boyle KP, Wright K (1994) Hum Antibodies Hybridomas 5: 25–31.
Toyokuni T, Hakomori S, Singhal AK (1994) Bioorg Med Chem 2: 1119–32.
Springer GF, Desai PR, Murthy MS, Tegtmeyer H, Scanlon EF (1979) Prog Allergy 26: 42–96.
Jensen T, Galli-Stampino L, Mouritsen S, Frische K, Peters S, Meldal M, Werdelin O (1996) Eur J Immunol 26: 1342–49.
Hansen JE, Nielsen C, Arendrup M, Olofsson S, Mathiesen L, Nielsen JO, Clausen H (1991) J Virol 65: 6461–7.
Springer GF, Desai PR, Banatwala I (1974) Naturwissenschaften 61: 457–8.
Hirohashi S, Clausen H, Yamada T, Shimosato Y, Hakomori S (1985) Proc Natl Acad Sci USA 82: 7039–43.
Nakada H, Numata Y, Inoue M, Tanaka N, Kitagawa H, Funakoshi I, Fukui S, Yamashina I (1991) Biol Chem 266: 12402–5.
Nakada H, Inoue M, Numata Y, Tanaka N, Funakoshi J, Fukui S, Mellors A, Yamashina I (1993) Proc Natl Acad Sci 90: 2495–9.
Huang J, Byrd JC, Siddiki B, Yuan M, Lau E, Kim YS (1992) Dis Markers 10: 81–94.
Carraway KL, Hull SR (1991) Glycobiology 1: 131–8.
Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport TA, Kim YS (1989) J Biol Chem 264: 6480–7.
Gendler SJ, Lancaster CA, Taylor-Papadimitrou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani E, Wilson D (1990) J Biol Chem 265: 1286–93.
Sørensen T, White T, Wandall HH, Kristensen AK, Roepstorff P, Clausen H (1995) J Biol Chem 270: 24166–73.
White T, Bennett EP, Takio K, Sørensen T, Bonding N, Clausen H (1995) J Biol Chem 270: 24156–65.
Bennett EP, Hassan H, Clausen H (1996) J Biol Chem 271: 17006–12.
Clausen H, Stroud M, Parker J, Springer G, Hakomori S (1988) Mol Immunol 25: 199–204.
Vuljanic T, Bergquist K-E, Clausen H, Roy S, Kihlberg J (1996) Tetrahedron 52: 7983–8000.
Hill HD, Reynolds JA, Hill RL (1977) J Biol Chem 252: 3791–7.
Baeckström D, Hansson GC, Nilson O, Johansson C, Gendler SJ, Lindholm L (1991) J Biol Chem 266: 21537–47.
Sojar HT, Bahl OP (1987) Methods in Enzymology 138: 341–50, San Diego: Academic Press.
Kirkeby S, Bøg-Hansen C, Moe D (1992) J Histochem Cytochem 40: 1511–16.
Hsu SM, Raine L, Fanger H (1981) Am J Clin Pathol 75: 816–21.
Gooley AA, Pisano A, Packer NH, Ball M, Jones A, Alewood PF, Redmond JW, Williams KL (1994) Glycoconjugate J 11: 180–86.
Dyrberg T, Oldstone MBA (1986) J Exp Med 164: 1344–9.
Schaaper WMM, Lankhof H, Pujik WC, Meloen RH (1989) Mol Immunol 26: 81–5.
Xing P, Prenzoska J, Layton GT, Devine PI, McKenzie IFC (1992) J Natl Cancer Inst 84: 699–703.
Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim, YS (1993) Cancer Res 53: 641–51.
Gambús G, DeBolós C, Andreu D, FrancíC, Egea G, Real FX (1993) Gastroenterology 104: 93–102.
Devine PL, McGuckin MA, Birrell GW, Whitehead RH, Sachdev GP, Shield P, Ward BG (1993) Br J Cancer 67: 1182–8.
Ørntoft TF, Harving N, Langkilde NC (1990) Int J Cancer 45: 666–72.
Slomiany A, Zdebska E, Slomiany BL (1984) J Biol Chem 259: 14743–9.
Podolsky DK (1985) J Biol Chem 260: 15510–15.
Matsuura H, Greene T, Hakomori S (1988) J Biol Chem 263: 3314–22.
Hanisch F-G, Stadie T, Bolet K (1995) Cancer Res 55: 4036–40.
Jansson AM, Meldal M, Bock K (1992) J Chem Soc, Perkin Trans 1: 1699–707.
Elofsson M, Roy S. Walse B, Kihlberg J (1993) Carbohydr Res 246: 89–103.
Bock K, Stuike-Prill R, Medal M (1993) In Proc 36th Alfred Benzon Symp (Bock K, Clausen H, eds) pp 229–42. Copenhagen: Munksgaard.
Gerz M, Matter H, Kessler H (1994) Int J Pept Protein Res 43: 248–57.
Urge L, Jackson DC, Gorbics L, Wroblewski K, Graczyk G, Otvos L Jr (1994) Tetrahedron 50: 2373–90.
Medal M, Bock K (1994) Glycoconjugate J 11: 59–63.
Kihlberg J, Åhman J, Walse B, Drakenberg T, Nilsson A, Söderberg-Ahlm C, Bengtsson B, Olsson H (1995) J Med Chem 38: 161–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reis, C.A., Sørensen, T., Mandel, U. et al. Development and characterization of an antibody directed to an α-N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconj J 15, 51–62 (1998). https://doi.org/10.1023/A:1006939432665
Issue Date:
DOI: https://doi.org/10.1023/A:1006939432665